Dr. Tassavor is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1033 Clifton Ave STE 201
Clifton, NJ 07013Phone+1 973-777-6444
Education & Training
Uconn School Of MedicineClass of 2018
Certifications & Licensure
NJ State Medical License 2023 - 2025
NY State Medical License 2023 - 2025
OH State Medical License 2022 - 2024
MA State Medical License 2018 - 2019- American Board of Dermatology Dermatology
Publications & Presentations
PubMed
- 1 citationsImproving melanoma reporting: The Ohio Model.Matthew DaCunha, Michael Tassavor, Madalyn Bland South, Brett Coldiron
Journal of the American Academy of Dermatology. 2024-11-01 - 4 citationsUse of the 40-gene Expression Profile (40-GEP) Test in Medicare-eligible Patients Diagnosed with Cutaneous Squamous Cell Carcinoma (cSCC) to Guide Adjuvant Radiation T...Ally-Khan Somani, Sherrif F Ibrahim, Michael Tassavor, Jane Yoo, Aaron S Farberg
The Journal of Clinical and Aesthetic Dermatology. 2024-01-01 - 3 citationsEstimated cost efficacy of U.S. Food and Drug Administration-approved treatments for acne.Michael Tassavor, Michael J. Payette
Dermatologic Therapy. 2019-01-01
Press Mentions
Castle Biosciences’ Gene Expression Profile Test Effectively Predicts Sentinel Lymph Node PositivityOctober 6th, 2023- Castle Biosciences to Present New Data Highlighting the Clinical Value of Its Dermatologic Tests for Patients with Skin Cancer at the 2024 American Academy of Dermatology (AAD) Annual MeetingMarch 9th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
